Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Rapid Micro Biosystems Inc Cl A (RPID)

Rapid Micro Biosystems Inc Cl A (RPID)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 135,473
  • Shares Outstanding, K 41,942
  • Annual Sales, $ 23,230 K
  • Annual Income, $ -73,520 K
  • 60-Month Beta 1.25
  • Price/Sales 6.30
  • Price/Cash Flow N/A
  • Price/Book 0.75
Trade RPID with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.37
  • Number of Estimates 2
  • High Estimate -0.36
  • Low Estimate -0.38
  • Prior Year -0.39
  • Growth Rate Est. (year over year) +5.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.05 +5.90%
on 09/02/22
3.78 -14.55%
on 09/16/22
-0.16 (-4.72%)
since 08/30/22
3-Month
2.83 +14.21%
on 08/22/22
4.87 -33.68%
on 08/03/22
-1.07 (-24.88%)
since 06/30/22
52-Week
2.49 +29.72%
on 06/17/22
22.71 -85.78%
on 11/04/21
-15.24 (-82.51%)
since 09/30/21

Most Recent Stories

More News
Rapid Micro Biosystems, Inc. (RPID) Q2 2022 Earnings Call Transcript

RPID earnings call for the period ending June 30, 2022.

RPID : 3.23 (-7.45%)
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Lags Revenue Estimates

Rapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of 11.43% and 24.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?...

RPID : 3.23 (-7.45%)
MDT : 80.75 (-1.85%)
Fortress Biotech (FBIO) Reports Q2 Loss, Misses Revenue Estimates

Fortress Biotech (FBIO) delivered earnings and revenue surprises of -20% and 17.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

FBIO : 0.8600 (+0.67%)
RPID : 3.23 (-7.45%)
Rapid Micro Biosystems to Announce Second Quarter 2022 Financial Results on August 12, 2022

LOWELL, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology...

RPID : 3.23 (-7.45%)
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates

ConforMIS (CFMS) delivered earnings and revenue surprises of -12.50% and 1.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CFMS : 0.1912 (-10.99%)
RPID : 3.23 (-7.45%)
Rapid Micro Biosystems Confirms Receipt of Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management

Shareholders Do Not Need to Take Action at This Time...

RPID : 3.23 (-7.45%)
Rapid Micro Biosystems, Inc. (RPID) Q1 2022 Earnings Call Transcript

RPID earnings call for the period ending March 31, 2022.

RPID : 3.23 (-7.45%)
Rapid Micro Biosystems Reports First Quarter 2022 Financial Results

Reports first quarter 2022 commercial revenue of $4.2 million Reaffirms full year 2022 commercial revenue outlook range of $27 million to $32 million,...

RPID : 3.23 (-7.45%)
Rapid Micro Biosystems to Announce First Quarter 2022 Financial Results on May 10, 2022

LOWELL, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology...

RPID : 3.23 (-7.45%)
Wall Street Analysts Think Rapid Micro Biosystems, Inc. (RPID) Could Surge 310%: Read This Before Placing a Bet

The mean of analysts' price targets for Rapid Micro Biosystems, Inc. (RPID) points to a 309.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...

RPID : 3.23 (-7.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Rapid Micro Biosystems Inc. is a life sciences technology company. It provides automation solutions to healthcare products. Rapid Micro Biosystems Inc. is based in LOWELL, Mass.

See More

Key Turning Points

3rd Resistance Point 4.00
2nd Resistance Point 3.84
1st Resistance Point 3.53
Last Price 3.23
1st Support Level 3.07
2nd Support Level 2.92
3rd Support Level 2.61

See More

52-Week High 22.71
Fibonacci 61.8% 14.99
Fibonacci 50% 12.60
Fibonacci 38.2% 10.21
Last Price 3.23
52-Week Low 2.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar